copanlisib
Copanlisib is a drug used to treat Anatomic Stage IV Breast Cancer AJCC v8, Follicular Lymphoma, Metastatic Breast Carcinoma, and other conditions. Copanlisib is being actively studied in 30 studies and prior, has been studied in 2.
Top Sponsors | Top Sites | Top Investigators |
---|---|---|
National Cancer Institute (NCI) | M D Anderson Cancer Center | Jennifer Crombie |
M.D. Anderson Cancer Center | Dana-Farber Cancer Institute | Benedito A Carneiro, MD |
Memorial Sloan Kettering Cancer Center | Memorial Sloan Kettering Cancer Center | Christian Buske |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
Z
Recruiting
- Non Small Cell Lung Cancer
- Durvalumab
- Copanlisib
- Lexington, KentuckyMarkey Cancer Center
2022-02-21
Feb 21, 2022N
Recruiting
- Follicular Lymphoma
- +2 more
- Rituximab
- Copanlisib
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022D
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
- +2 more
- Ibrutinib
- Copanlisib
- Boston, MassachusettsDana-Farber Cancer Institute
2021-09-08
Sep 8, 2021D
Recruiting
- Diffuse Large B Cell Lymphoma
- +2 more
- Copanlisib
- Venetoclax
- Boston, MassachusettsDana-Farber Cancer Institute
2021-09-08
Sep 8, 2021M
Not yet recruiting
- Endometrial Cancer
- Ovarian Cancer
- Copanlisib
- fulvestrant
- Houston, TexasM D Anderson Cancer Center
2022-03-31
Mar 31, 2022D
Recruiting
- Leukemia, Acute Lymphocytic
- Copanlisib
- Durham, North CarolinaDuke Cancer Center
2021-07-19
Jul 19, 2021H
Completed
- Biliary Carcinoma
- +3 more
- Cisplatin
- +2 more
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
2021-08-03
Aug 3, 2021S
C
Active, not recruiting
- HER2 Positive Breast Cancer
- Copanlisib
- Trastuzumab
- Cork, Ireland
- +4 more
2021-10-08
Oct 8, 2021M
Not yet recruiting
- Locally Advanced Malignant Solid Neoplasm
- +3 more
- Copanlisib
- Elimusertib
- Houston, TexasM D Anderson Cancer Center
2021-08-10
Aug 10, 2021C
Recruiting
- Follicular Lymphoma
- Endometrial Cancer
- Copanlisib
- Ketogenic Diet
- New York, New York
- +2 more
2021-11-24
Nov 24, 2021B
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- Rucaparib
- Copanlisib
- San Francisco, California
- +1 more
2021-11-18
Nov 18, 2021N
Recruiting
- Burkitt Lymphoma
- +4 more
- Rituximab
- +6 more
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022C
Recruiting
- Chronic Lymphocytic Leukemia
- +6 more
- Copanlisib
- Nivolumab
- Duarte, California
- +2 more
2022-03-09
Mar 9, 2022B
Active, not recruiting
- Non-small Cell Lung Cancer (NSCLC)
- +2 more
- Copanlisib
- Nivolumab
- Beverly Hills, California
- +5 more
2022-03-28
Mar 28, 2022U
Recruiting
- Diffuse Large B Cell Lymphoma
- Copanlisib
- R-CHOP Chemotherapy
- Aachen, Germany
- +9 more
2021-10-19
Oct 19, 2021B
Recruiting
- Indolent Lymphoma
- Copanlisib
- +2 more
- Chicago, Illinois
- +3 more
2021-10-26
Oct 26, 2021U
Terminated
- Lymphoid Leukemia
- +3 more
- Copanlisib
- +2 more
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2021-07-20
Jul 20, 2021M
Recruiting
- Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL)
- Ibrutinib
- Copanlisib
- Basking Ridge, New Jersey
- +6 more
2022-03-28
Mar 28, 2022M
Active, not recruiting
- Mantle Cell Lymphoma (MCL)
- Copanlisib
- Ibrutinib
- Basking Ridge, New Jersey
- +5 more
2021-04-14
Apr 14, 2021N
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +3 more
- Copanlisib
- Fulvestrant
- Sacramento, California
- +7 more
2022-03-25
Mar 25, 2022C
Terminated
- HER2-positive Breast Cancer
- +3 more
- Copanlisib
- Trastuzumab emtansine
- Cork, Ireland
- +3 more
2020-12-14
Dec 14, 2020J
Active, not recruiting
- Estrogen Receptor Positive
- +16 more
- Biopsy of Breast
- +5 more
- Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
2021-10-07
Oct 7, 2021M
Recruiting
- Thyroid Carcinoma
- +5 more
- I-124 PET/CT lesion dosimetry
- +2 more
- Basking Ridge, New Jersey
- +6 more
2022-03-03
Mar 3, 2022C